Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated thebest-in-class platform and initiated multiple programs across different disease areas.

Biotechnology

Therapeutics

TRIANA Biomedicines

Patrick Trojer

Christine Petersen (Wenzel)

Andrew Conery

Vito Palombella

Brenda Sousa

Karen Valentine

Tim Wigle

Daniel La

Kathleen Seyb

Reza Mazhari

Jesse Chen

The Leadership Team at TRIANA Biomedicines is responsible for steering the strategic vision and overall direction of the company. Comprised of experts in scientific research, business development, and drug discovery, they collaborate to shape innovative approaches to disease treatment, oversee the advancement of the molecular glue platform, and ensure alignment between scientific goals and commercial objectives. This team plays a critical role in fostering partnerships, driving program initiatives, and guiding the company’s growth in the biopharmaceutical landscape.

Leadership Team

Biology and Chemistry Functions

Research and Development

Leadership Team

About

Team members

Other teams at TRIANA Biomedicines

Biology and Chemistry Functions

Research and Development